Results 81 to 90 of about 3,944 (168)

Identification of Two Novel LAMA2 Mutations in a Chinese Patient with Congenital Muscular Dystrophy

open access: yesFrontiers in Genetics, 2018
Merosin-deficient CMD type 1A (MDC1A), caused by mutations of laminin subunit alpha 2 (LAMA2), is a predominant subtype of congenital muscular dystrophy (CMD).
Jing Zhou   +8 more
doaj   +1 more source

LAMA2 Gene Analysis in Congenital Muscular Dystrophy

open access: yes, 2005
n ...
Di Blasi, Claudia   +14 more
openaire   +1 more source

Pericytes Favor Oligodendrocyte Fate Choice in Adult Neural Stem Cells

open access: yesFrontiers in Cellular Neuroscience, 2019
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Upon demyelination, oligodendrocyte progenitor cells (OPCs) are activated and they proliferate, migrate and differentiate into myelin-producing ...
Maria Elena Silva   +29 more
doaj   +1 more source

Diseased muscles that lack dystrophin or laminin-α2 have altered compositions and proliferation of mononuclear cell populations

open access: yesBMC Neurology, 2005
Background Multiple types of mononucleate cells reside among the multinucleate myofibers in skeletal muscles and these mononucleate cells function in muscle maintenance and repair.
Miller Jeffrey   +2 more
doaj   +1 more source

Reviewing Large LAMA2 Deletions and Duplications in Congenital Muscular Dystrophy Patients

open access: yesJournal of Neuromuscular Diseases, 2014
Background: Congenital muscular dystrophy (CMD) type 1A (MDC1A) is caused by recessive mutations in laminin-α2 (LAMA2) gene. Laminin-211, a heterotrimeric glycoprotein that contains the α2 chain, is crucial for muscle stability establishing a bond between the sarcolemma and the extracellular matrix.
Jorge, Oliveira   +8 more
openaire   +3 more sources

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient

open access: yesCase Reports in Genetics, 2018
Congenital muscle dystrophies (CMD) are genetically and clinically heterogeneous hereditary myopathies mainly with autosomal recessive type of inheritance.
Ivanka Dimova, Ivo Kremensky
doaj   +1 more source

Novel sequence variations in LAMA2 and SGCG genes modulating cis-acting regulatory elements and RNA secondary structure

open access: yesGenetics and Molecular Biology, 2010
In this study, we detected new sequence variations in LAMA2 and SGCG genes in 5 ethnic populations, and analysed their effect on enhancer composition and mRNA structure.
Olfa Siala   +5 more
doaj  

Evaluation of Some Proteins as Potential Markers in Different Durations of Diabetic Patients Type 2  

open access: yesIbn Al-Haitham Journal for Pure and Applied Sciences
Type 2 diabetic mellitus (T2DM) is growing rapidly around the world, due in large part to significant changes in the modern human lifestyle. T2DM and its complications are affected by a complex interplay of genetic, life course, ecological, cultural ...
Sarah Sameer Sami, Ekhlass M. Taha
doaj   +1 more source

Dual AAV amelioration of Lama2-null muscular dystrophy and neuropathy

open access: yes
ABSTRACT The dy 3K /dy 3K Lama2 -/- mouse is a model for the severe form of LAMA2-related dystrophy and ...
Karen K. McKee, Peter D. Yurchenco
openaire   +2 more sources

Home - About - Disclaimer - Privacy